Bu web sitesi, size mümkün olan en iyi kullanıcı deneyimini sunabilmek için çerezleri kullanır. Çerez bilgileri tarayıcınızda saklanır ve web sitemize döndüğünüzde sizi tanımak ve ekibimizin web sitesinin hangi bölümlerini en ilginç ve yararlı bulduğunuzu anlamasına yardımcı olmak gibi işlevleri yerine getirir.
Proven in more clinical studies than any other single-injection hyaluronic acid knee therapy, DUROLANE has been shown to be safe and effective.
During the DUROLANE pivotal trial:17
- No serious adverse events were considered related to DUROLANE treatment.17
- The most common adverse events were arthralgia (8.6%), injection site pain (2.3%), and joint swelling (1.7%).17
DUROLANE is safe for repeated courses of therapy. Repeat administration of a course of DUROLANE therapy does not increase the incidence of adverse events.10,17
Choose DUROLANE for Longer-lasting Results
- Increased residence time in the knee joint ‡27,29-32
- A half-life of 4 weeks in the knee joint, in both animals and humans.16,29
- The longest reported half-life of any hyaluronic acid product.29-32
‡The clinical relevance of this information has not been determined.